simvastatin sold brand name zocor among others statin type lipidlowering used along exercise diet weight loss decrease elevated lipid also used decrease risk heart problems high taken common side effects include constipation headaches serious side effects may include muscle breakdown liver problems increased blood sugar lower dose may needed people kidney evidence harm developing baby taken used statin class medications works decreasing manufacture cholesterol simvastatin made fungus aspergillus patented merck came medical use simvastatin available generic world health organizations list essential thirteenth commonly prescribed medication united states million primary uses simvastatin treat dyslipidemia prevent atherosclerosisrelated complications stroke heart attacks high recommended used addition lowcholesterol heart protection studies simvastatin showed ability lower ldl cholesterol mmoll resulted substantial reductions mortality rates simvastatin also reduced numbers events like heart attacks strokes revascularizations mi heart protection study evaluated effects simvastatin people risk factors including existing cardiovascular disease diabetes stroke relatively low ldl cholesterol trial lasted years overall mortality reduced cardiovascular mortality reduced people receiving simvastatin experienced fewer nonfatal heart attacks fewer statins general proposed beneficial reducing progression agerelated macular degeneration multiple observational studies analyse benefits statin use delaying progression amd resulted conflicting outcomes given current available information simvastatin recommended solely treatment amd simvastatin contraindicated pregnancy breastfeeding liver pregnancy must avoided simvastatin due potentially severe birth defects patients breastfeed simvastatin due potentially disrupting infants lipid high doses simvastatin also contraindicated widely used antihypertensive lower dose also recommended people taking calcium channel blockers verapamil diltiazem well taking common side effects incidence may include indigestion eczema evidence suggest rare side effects joint pain memory loss muscle cramps likely occur patients take higher doses cholestatic hepatitis hepatic cirrhosis rhabdomyolysis destruction muscles blockade renal system myositis reported patients receiving drug serious allergic reactions simvastatin type dna variant known single nucleotide polymorphism snp may help predict individuals prone developing myopathy taking simvastatin study ultimately including patients concluded carriers one two risk alleles particular snp fivefold increased risk clinical pharmacogenetics implementation consortium released guidelines regarding use genotype guiding dosing updated guideline march us food drug administration fda updated guidance statin users address reports memory loss liver damage increased blood sugar development type diabetes muscle new guidance indicates march fda issued another statement regarding simvastatin saying increases risk muscle injury myopathy taken high doses lower doses combination highest dose rate causes muscle damage every people contrast lower dose causes muscle damage eight fda warning released june suggested highdose simvastatin used patients taking dose months without evidence muscle injury started new patients including patients already taking lower doses simvastatin important interactions grapefruit juice drugs including commonly used treatment cardiovascular disease interactions clinically important increasing simvastatin serum levels normally provided maximum recommended dose increases risk muscle damage including otherwise rare potentially fatal side effect consuming large amounts grapefruit juice increases serum levels simvastatin threefold increasing risk side fda recommends people taking statins avoid consuming quart ml grapefruit juice per simvastatin also interacts drugs including used treat cardiovascular problems taken people also taking antifungal drugs fluconazole itraconazole posaconazole antibiotics erythromycin clarithromycin telithromycin hiv protease inhibitors antidepressant nefazodone cardiovascular drug gemfibrozil immunosuppressant ciclosporin endometriosis drug danazol reduced maximum doses simvastatin apply patients taking certain drugs including cardiovascular drugs verapamil diltiazem amiodarone amlodipine statins act inhibiting hmg coenzyme reductase hmgcoa reductase ratelimiting enzyme hmgcoa reductase pathway metabolic pathway responsible endogenous production cholesterol statins effective lipidregulating drugs lowering ldlcholesterol concentration less effective fibrates reducing triglyceride concentration however statins reduce cardiovascular disease events total mortality irrespective initial cholesterol concentration major piece evidence statins work another way lowering cholesterol called pleiotropic drug form inactive lactone hydrolyzed ingestion produce active agent white nonhygroscopic crystalline powder practically insoluble water freely soluble chloroform methanol ethanol simvastatin effective serum lipidlowering drug decrease low density lipoprotein ldl levels needed simvastatin shown interact lipidlowering transcription factor interaction might control neurotrophic action drug development simvastatin closely linked lovastatin biochemist jesse huff colleagues merck began researching biosynthesis cholesterol early mevalonic acid isolated yeast extract karl folkers carl hoffman others merck huff associates confirmed mevalonic acid intermediate cholesterol biosynthesis hmgcoa reductase enzyme major contributor internal cholesterol production discovered researchers max planck institute discovery encouraged scientists worldwide find effective inhibitor akira endo isolated first inhibitor mevastatin fungus penicillium citrinium working daiichi sankyo hoffman colleagues isolated lovastatin strain fungus aspergillus terreus developing researching lovastatin merck scientists synthetically derived potent hmgcoa reductase inhibitor fermentation product terreus designated later named publication results scandinavian simvastatin survival study provided first unequivocal evidence lowering ldl cholesterol via statin treatment reduces cardiovascular events overall mortality total people coronary heart disease blood cholesterol levels mmoll randomized simvastatin treatment placebo followed average years compared placebo group treated simvastatin experienced decrease overall mortality reduction coronary death reduction major coronary events reduction revascularization prior losing us patent protection simvastatin merck cos largestselling provisions patient protection affordable care act ppaca united states health plans may cover costs simvastatin mg mg mg adults aged years based united states preventive services task force uspstf zocor original patent expiry date december extended united states patent trademark office uspto expire june uspto granted patent extension merck submitted data studies drugs positive effect childrencitation needed uk patent simvastatin expired needed simvastatin initially marketed merck co brand name zocor available generically countries following patent expirycitation needed combination simvastatin along ezetimibe sold brand name vytorin jointly marketed merck scheringploughcitation needed brand names include zocor zocor heart pro marketed pharmaceutical company merck co simlup simvotin simcard india denan germany liponorm sinvacor sivastin italy lipovas japan lodales france zocord austria sweden zimstat simvahexal australia lipex australia new zealand simvastatinteva simvacor simvaxon simovil israel available thailand brand bestatin manufactured berlin pharmaceutical industry co ltd otherscitation needed us patent zocor expired june httpsenwikipediaorgwikisimvastatin